Trials / NCT04281732
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Completed Observational Natural history / observational
- Sponsor
- Queen's University, Belfast
- Treatment
- Virtual Reality Headset based tests
- Gene
- Not stated
- Conditions
- Low Vision, Retinitis Pigmentosa, Stargardt Disease 1, Stargardt Disease 3, Stargardt Disease 4, Albinism
- Ages
- 20 Years to 50 Years
- Enrollment
- 18 participants
- Started
- 2018-10-01
- Main results expected
- 2021-12-31
- Results posted
- Not yet
- Record last updated
- 2026-10-26
What the study is testing
Purpose:
To validate a newly developed battery of performance-based tests of visual function to be presented using virtual reality. The tests are intended as potential outcome measures for clinical trials of treatments of eye disease: they measure visual performance in patients with low vision on visual tasks that a relevant for daily life.
Where it runs
United Kingdom (1)
- NI Clinical Research Facility, Belfast, Northern Ireland